119 related articles for article (PubMed ID: 12219874)
1. Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats.
Llinás MT; Alexander BT; Seedek M; Abram SR; Crell A; Granger JP
Am J Hypertens; 2002 Sep; 15(9):793-7. PubMed ID: 12219874
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
Wilcox CS; Welch WJ; Snellen H
Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats.
Llinás MT; Alexander BT; Capparelli MF; Carroll MA; Granger JP
Hypertension; 2004 Mar; 43(3):623-8. PubMed ID: 14757776
[TBL] [Abstract][Full Text] [Related]
4. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats.
Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ
Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827
[TBL] [Abstract][Full Text] [Related]
5. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.
Alexander BT; Rinewalt AN; Cockrell KL; Massey MB; Bennett WA; Granger JP
Hypertension; 2001 Feb; 37(2 Pt 2):485-9. PubMed ID: 11230323
[TBL] [Abstract][Full Text] [Related]
6. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade.
Mistry M; Muirhead EE; Yamaguchi Y; Nasjletti A
J Hypertens; 1990 Jan; 8(1):75-83. PubMed ID: 2157760
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats.
Alexander BT; Cockrell K; Cline FD; Llinas MT; Sedeek M; Granger JP
Hypertension; 2001 Sep; 38(3 Pt 2):742-5. PubMed ID: 11566968
[TBL] [Abstract][Full Text] [Related]
8. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6.
Gadonski G; LaMarca BB; Sullivan E; Bennett W; Chandler D; Granger JP
Hypertension; 2006 Oct; 48(4):711-6. PubMed ID: 16940225
[TBL] [Abstract][Full Text] [Related]
9. L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure.
Alexander BT; Llinas MT; Kruckeberg WC; Granger JP
Hypertension; 2004 Apr; 43(4):832-6. PubMed ID: 14769812
[TBL] [Abstract][Full Text] [Related]
10. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats.
Gilbert J; Dukes M; LaMarca B; Cockrell K; Babcock S; Granger J
Am J Hypertens; 2007 Jun; 20(6):686-91. PubMed ID: 17531929
[TBL] [Abstract][Full Text] [Related]
11. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.
LaMarca BB; Bennett WA; Alexander BT; Cockrell K; Granger JP
Hypertension; 2005 Oct; 46(4):1022-5. PubMed ID: 16144982
[TBL] [Abstract][Full Text] [Related]
12. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion.
Roberts L; LaMarca BB; Fournier L; Bain J; Cockrell K; Granger JP
Hypertension; 2006 Mar; 47(3):615-8. PubMed ID: 16391174
[TBL] [Abstract][Full Text] [Related]
13. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats.
Sholook MM; Gilbert JS; Sedeek MH; Huang M; Hester RL; Granger JP
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2080-4. PubMed ID: 17644567
[TBL] [Abstract][Full Text] [Related]
14. Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia.
Vaka VR; McMaster KM; Cunningham MW; Ibrahim T; Hazlewood R; Usry N; Cornelius DC; Amaral LM; LaMarca B
Hypertension; 2018 Sep; 72(3):703-711. PubMed ID: 30012871
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
Reyes AA; Klahr S
Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
[TBL] [Abstract][Full Text] [Related]
16. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
Felsen D; Loo MH; Marion DN; Vaughan ED
J Urol; 1990 Jul; 144(1):141-5. PubMed ID: 2141654
[TBL] [Abstract][Full Text] [Related]
17. Importance of prostaglandins in hypertension during reduced uteroplacental perfusion pressure.
Woods LL
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1558-61. PubMed ID: 2604012
[TBL] [Abstract][Full Text] [Related]
18. Renal vasoconstriction with U-46,619; role of arachidonate metabolites.
Wilcox CS; Folger WH; Welch WJ
J Am Soc Nephrol; 1994 Oct; 5(4):1120-4. PubMed ID: 7849252
[TBL] [Abstract][Full Text] [Related]
19. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats.
Sedeek M; Gilbert JS; LaMarca BB; Sholook M; Chandler DL; Wang Y; Granger JP
Am J Hypertens; 2008 Oct; 21(10):1152-6. PubMed ID: 18670418
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
